Novonesis Q3 Adjusted EBITDA Margin 37.9% vs. 38% Consensus
Novonesis reported a Q3 adjusted EBITDA margin of 37.9%, compared with 38% in company consensus.
Novonesis reported a Q3 adjusted EBITDA margin of 37.9%, compared with 38% in company consensus.